Douglas Lane & Associates, LLC Novartis Ag Transaction History

Douglas Lane & Associates, LLC

  • $6.7 Billion
  • Q2 2025

A detailed history of Douglas Lane & Associates, LLC transactions in Novartis Ag stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 165,271 shares of NVS stock, worth $20.3 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
165,271
Previous 169,475 2.48%
Holding current value
$20.3 Million
Previous $18.9 Million 5.85%
% of portfolio
0.3%
Previous 0.29%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025
SELL
$101.96 - $121.01 $428,639 - $508,726
-4,204 Reduced 2.48%
165,271 $20 Million
Q1 2025

Apr 09, 2025
BUY
$97.14 - $115.57 $1.12 Million - $1.33 Million
11,501 Added 7.28%
169,475 $18.9 Million
Q4 2024

Jan 08, 2025
SELL
$96.78 - $117.18 $665,749 - $806,081
-6,879 Reduced 4.17%
157,974 $15.4 Million
Q3 2024

Oct 10, 2024
SELL
$106.13 - $120.89 $1.32 Million - $1.5 Million
-12,449 Reduced 7.02%
164,853 $19 Million
Q2 2024

Jul 08, 2024
SELL
$92.57 - $107.37 $246,421 - $285,818
-2,662 Reduced 1.48%
177,302 $18.9 Million
Q1 2024

Apr 11, 2024
BUY
$95.27 - $108.47 $500,453 - $569,792
5,253 Added 3.01%
179,964 $17.4 Million
Q4 2023

Jan 17, 2024
SELL
$92.27 - $101.54 $610,550 - $671,890
-6,617 Reduced 3.65%
174,711 $17.6 Million
Q3 2023

Oct 16, 2023
SELL
$94.73 - $105.13 $1.29 Million - $1.43 Million
-13,609 Reduced 6.98%
181,328 $18.5 Million
Q2 2023

Jul 19, 2023
SELL
$92.52 - $104.91 $1.21 Million - $1.37 Million
-13,067 Reduced 6.28%
194,937 $19.7 Million
Q1 2023

Apr 17, 2023
SELL
$80.03 - $92.81 $988,530 - $1.15 Million
-12,352 Reduced 5.61%
208,004 $19.1 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $31,353 - $38,395
-415 Reduced 0.19%
220,356 $20 Million
Q4 2022

Jan 17, 2023
SELL
$75.55 - $92.52 $6.05 Million - $7.4 Million
-80,035 Reduced 26.61%
220,771 $20 Million
Q3 2022

Oct 14, 2022
SELL
$74.61 - $87.26 $1.86 Million - $2.17 Million
-24,900 Reduced 7.64%
300,806 $22.9 Million
Q2 2022

Jul 18, 2022
SELL
$80.52 - $93.75 $528,050 - $614,812
-6,558 Reduced 1.97%
325,706 $27.5 Million
Q1 2022

Apr 25, 2022
SELL
$80.11 - $90.62 $3.75 Million - $4.24 Million
-46,825 Reduced 12.35%
332,264 $29.2 Million
Q4 2021

Jan 25, 2022
SELL
$79.7 - $88.13 $15.5 Million - $17.1 Million
-194,230 Reduced 33.88%
379,089 $33.2 Million
Q3 2021

Oct 21, 2021
SELL
$81.78 - $95.14 $6.48 Million - $7.54 Million
-79,248 Reduced 12.14%
573,319 $46.9 Million
Q2 2021

Jul 19, 2021
SELL
$85.24 - $94.15 $3.44 Million - $3.8 Million
-40,411 Reduced 5.83%
652,567 $59.5 Million
Q1 2021

Apr 19, 2021
BUY
$83.5 - $98.47 $4.96 Million - $5.85 Million
59,424 Added 9.38%
692,978 $59.2 Million
Q4 2020

Jan 14, 2021
BUY
$78.07 - $94.43 $4.41 Million - $5.33 Million
56,433 Added 9.78%
633,554 $59.8 Million
Q3 2020

Oct 19, 2020
BUY
$82.14 - $91.0 $13.3 Million - $14.8 Million
162,375 Added 39.15%
577,121 $50.2 Million
Q2 2020

Jul 28, 2020
BUY
$80.93 - $91.1 $2.76 Million - $3.11 Million
34,107 Added 8.96%
414,746 $36.2 Million
Q1 2020

Apr 20, 2020
BUY
$70.67 - $99.01 $1.76 Million - $2.47 Million
24,914 Added 7.0%
380,639 $31.4 Million
Q4 2019

Jan 27, 2020
BUY
$84.35 - $95.37 $1.22 Million - $1.38 Million
14,503 Added 4.25%
355,725 $33.7 Million
Q3 2019

Oct 16, 2019
SELL
$85.54 - $94.26 $169,454 - $186,729
-1,981 Reduced 0.58%
341,222 $29.7 Million
Q2 2019

Jul 08, 2019
BUY
$75.4 - $92.8 $875,469 - $1.08 Million
11,611 Added 3.5%
343,203 $31.3 Million
Q1 2019

Apr 23, 2019
BUY
$75.32 - $86.15 $54,682 - $62,544
726 Added 0.22%
331,592 $31.9 Million
Q4 2018

Jan 17, 2019
SELL
$73.66 - $82.02 $384,947 - $428,636
-5,226 Reduced 1.55%
330,866 $28.4 Million
Q3 2018

Oct 09, 2018
SELL
$66.94 - $77.43 $228,533 - $264,346
-3,414 Reduced 1.01%
336,092 $29 Million
Q2 2018

Jul 23, 2018
SELL
$64.91 - $73.36 $1.94 Million - $2.19 Million
-29,899 Reduced 8.09%
339,506 $25.6 Million
Q1 2018

Apr 23, 2018
SELL
$70.39 - $84.15 $545,100 - $651,657
-7,744 Reduced 2.05%
369,405 $29.9 Million
Q4 2017

Jan 24, 2018
SELL
$72.33 - $77.64 $817,184 - $877,176
-11,298 Reduced 2.91%
377,149 $31.7 Million
Q3 2017

Oct 19, 2017
BUY
$74.14 - $77.27 $28.8 Million - $30 Million
388,447
388,447 $33.3 Million

Others Institutions Holding NVS

# of Institutions
1,531
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $264B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email